Related Experiment Video
Updated: Jul 17, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Layered Double Hydroxide-Based Sonosensitizer Triggers "Paraptosis+" Multidimensional Cell Death Network for
Yu Yang1, Tingting Hu2, Yanfang Zhu1
1State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, P. R. China.
Abstract:
Paraptosis, a caspase-independent programmed cell death pathway characterized by cytoplasmic vacuolization, presents a promising alternative for overcoming apoptosis resistance. However, its clinical translation is hampered by the low reactive oxygen species (ROS) generation efficiency and insufficient anti-tumor efficacy of existing inducers. To address these limitations, we develop defective nickel-doped ZnMo-layered double hydroxide nanosheets (DR-Ni-ZnMo-LDH) as a new inducer for paraptosis-mediated sono-immunotherapy. Under ultrasound irradiation, the DR-Ni-ZnMo-LDH exhibits excellent singlet oxygen generation activity, superior to that of all the reported sonosensitizers. Mechanistic investigations reveal that the ROS burst generated by DR-Ni-ZnMo-LDH not only effectively induces paraptosis but also concurrently activates apoptosis and ferroptosis, thereby synergistically eliminating apoptosis-resistant tumor cells. In vitro and in vivo assays confirm that this multi-modal cell death strategy elicits robust immunogenic cell death, remodels the immunosuppressive tumor microenvironment, and significantly inhibits the growth of primary and distant tumors, with inhibition rates reaching 98.44% and 88.53%, respectively. This study establishes a new material design paradigm for ROS-mediated sono-immunotherapy based on paraptosis, effectively overcoming tumor resistance and immunosuppression through multi-mechanism synergy.
Insights
Researchers developed novel nanosheets to induce paraptosis (programmed cell death) and overcome tumor resistance. This sono-immunotherapy approach effectively eliminates cancer cells and inhibits tumor growth by combining multiple cell death pathways.
Area of Science:
- Biomaterials Science
- Cancer Therapy
- Immunology
Background:
- Paraptosis, a caspase-independent cell death, offers an alternative to overcome apoptosis resistance in cancer.
- Current paraptosis inducers face limitations due to low reactive oxygen species (ROS) generation and insufficient anti-tumor efficacy.
- Developing novel strategies to enhance paraptosis induction and anti-tumor activity is crucial for clinical translation.
Purpose of the Study:
- To develop a novel inducer for paraptosis-mediated sono-immunotherapy to overcome limitations of existing treatments.
- To investigate the synergistic effects of multi-modal cell death induced by the novel nanosheets.
- To evaluate the efficacy of the developed sono-immunotherapy in inhibiting primary and distant tumor growth.
Main Methods:
- Synthesis of defective nickel-doped ZnMo-layered double hydroxide nanosheets (DR-Ni-ZnMo-LDH).
- Evaluation of DR-Ni-ZnMo-LDH as a sonosensitizer for ROS generation under ultrasound irradiation.
- In vitro and in vivo studies to assess multi-modal cell death induction, immunogenic cell death, and tumor inhibition.
Main Results:
- DR-Ni-ZnMo-LDH demonstrated superior singlet oxygen generation activity under ultrasound irradiation.
- The ROS burst effectively induced paraptosis, apoptosis, and ferroptosis, synergistically eliminating apoptosis-resistant tumor cells.
- Significant inhibition of primary (98.44%) and distant (88.53%) tumor growth was observed, alongside remodeling of the immunosuppressive tumor microenvironment.
Conclusions:
- DR-Ni-ZnMo-LDH serves as an effective inducer for paraptosis-mediated sono-immunotherapy.
- The multi-modal cell death strategy overcomes tumor resistance and immunosuppression.
- This study presents a new material design paradigm for enhanced ROS-mediated sono-immunotherapy.
More Related Videos
09:05Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
Published on: July 22, 2015
07:16Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells
Published on: January 21, 2021